Page last updated: 2024-10-31

methylphenidate and Kussmaul Aphasia

methylphenidate has been researched along with Kussmaul Aphasia in 2 studies

Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chancellor, AM1
Frost, LH1

Other Studies

2 other studies available for methylphenidate and Kussmaul Aphasia

ArticleYear
Dissociative disorder, conversion disorder and the use of abreaction in a 22 year old male.
    The New Zealand medical journal, 1982, Jun-23, Volume: 95, Issue:710

    Topics: Abreaction; Adult; Amobarbital; Conversion Disorder; Dissociative Disorders; Humans; Male; Methylphe

1982
Methylphenidate in amytal-resistant mutism.
    Acta psychiatrica Scandinavica, 1989, Volume: 79, Issue:4

    Topics: Adult; Amobarbital; Humans; Infusions, Intravenous; Male; Methylphenidate; Mutism; Schizophrenia, Ca

1989